Christina Yau - Dissemin

All papers authored by Christina Yau

This paper was not found in any repository, but could be made available legally by the author.

2024 Mark Jesus M. Magbanua

, Ziad Ahmed

, Rosalyn W. Sayaman

, Lamorna Brown Swigart

, Gillian L. Hirst

, Christina Yau

, Denise M. Wolf

, Wen Li

, Amy L. Delson

, Jane Perlmutter

, Paula Pohlmann

, W. Fraser Symmans

, Douglas Yee

, Nola M. Hylton

, Laura J. Esserman

and 3 other authors

Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Kathy S. Albain, Christina Yau

, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan

, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark and 34 other authors

Supplementary Methods S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

Kathy S. Albain, Christina Yau

, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan

, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark and 34 other authors

Supplementary Table S4 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

Kathy S. Albain, Christina Yau

, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan

, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark and 34 other authors

Supplementary Table S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

Kathy S. Albain, Christina Yau

, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan

, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark and 34 other authors

Supplementary Table S2 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

Kathy S. Albain, Christina Yau

, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan

, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark and 34 other authors

Supplementary Table S3 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

Kathy S. Albain, Christina Yau

, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan

, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark and 34 other authors

Supplementary Figure S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

Kathy S. Albain, Christina Yau

, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan

, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark and 34 other authors

Data from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

Thomas O'Keefe, Christina Yau

, Emma Iaconetti, Eliza Jeong, Case Brabham, Paul Kim, Joseph McGuire, Ann Griffin, Anne M. Wallace, Laura J. Esserman, Olivier Harismendy, Gillian L. Hirst

Duration of Endocrine Treatment for DCIS impacts second events: Insights from a large cohort of cases at two academic medical centers

Upload

2023 Kathy S. Albain

, Christina Yau

, Emanuel F. Petricoin

, Denise M. Wolf

, Julie E. Lang

, A. Jo Chien

, Tufia Haddad

, Andres Forero-Torres

, Anne M. Wallace

, Henry Kaplan

, Lajos Pusztai

, David Euhus

, Rita Nanda

, Anthony D. Elias

, Amy S. Clark

and 34 other authors

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

This paper is made freely available by the publisher.

Yiwey Shieh

, Jacquelyn Roger

, Christina Yau

, Denise M. Wolf, Gillian L. Hirst

, Lamorna Brown Swigart

, Scott Huntsman, Donglei Hu

, Jovia L. Nierenberg, Pooja Middha

, Rachel S. Heise

, Yushu Shi, Linda Kachuri, Qianqian Zhu

, Song Yao

and 8 other authors

Development and testing of a polygenic risk score for breast cancer aggressiveness

Download from doi.org

2022 Annelie Johansson

, Huma Dar

, Laura J. van ’t Veer

, Nicholas P. Tobin, Gizeh Perez-Tenorio, Anna Nordenskjöld, Ulla Johansson, Johan Hartman, Lambert Skoog, Christina Yau

, Christopher C. Benz, Laura J. Esserman

, Olle Stål, Bo Nordenskjöld, Tommy Fornander and 1 other authors

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial

Download from doi.org

Julie E. Lang

, Andres Forero-Torres, Douglas Yee

, Christina Yau

, Denise Wolf, John Park, Barbara A. Parker, A. Jo Chien, Anne M. Wallace, Rashmi Murthy, Kathy S. Albain, Erin D. Ellis, Heather Beckwith, Barbara B. Haley, Anthony D. Elias and 34 other authors

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer

Download from www.nature.com

Adam Officer, Andre M. Dempsey, Lyndsay M. Murrow, Zev Gartner, Pablo Tamayo, Christina Yau

, Olivier Harismendy

Differential Analysis of Stromal-Epithelial Interactions between In Situ and Invasive Breast Cancer using Gene Expression Profiling

Upload

2021 Natsuko Onishi

, Wen Li

, David C. Newitt

, Roy J. Harnish, Fredrik Strand

, Alex Anh-Tu Nguyen, Vignesh Amal Arasu

, Jessica Gibbs

, Ella F. Jones

, Lisa J. Wilmes, John Kornak, Bonnie N. Joe

, Elissa R. Price

, Haydee Ojeda-Fournier

, Mohammad Eghtedari

and 46 other authors

Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response

Download from doi.org

Lajos Pusztai, Christina Yau

, Denise M. Wolf, Hyo S. Han, Lili Du, Anne M. Wallace, Erica String-Reasor

, Judy C. Boughey, A. Jo Chien, Anthony D. Elias, Heather Beckwith

, Rita Nanda, Kathy S. Albain, Amy S. Clark, Kathleen Kemmer and 30 other authors

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Upload

A. Gordon Robertson, Christina Yau

, Jian Carrot-Zhang

, Jeffrey S. Damrauer

, Theo A. Knijnenburg, Nyasha Chambwe

, Katherine A. Hoadley

, Anab Kemal, Jean C. Zenklusen, Andrew D. Cherniack, Rameen Beroukhim, Wanding Zhou

Integrative modeling identifies genetic ancestry-associated molecular correlates in human cancer

Download from doi.org

Mark Jesus M. Magbanua

, Wen Li

, Denise M. Wolf, Christina Yau

, Gillian L. Hirst

, Lamorna Brown Swigart

, David C. Newitt

, Jessica Gibbs, Amy L. Delson, Ekaterina Kalashnikova, Alexey Aleshin, Bernhard Zimmermann

, A. Jo Chien, Debu Tripathy

, Laura Esserman

and 2 other authors

Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk

Download from www.nature.com

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Christina Yau